Allison Tomek

President, IR & Equilitix

Allison Tomek is a seasoned investor relations executive, with more than 20 years of experience in investor relations, corporate communications, and corporate governance practices. She has held investor relations and corporate communications roles at NYSE, NASDAQ, the former AMEX, and OTC companies. Her experience covers a variety of industries including railroads, pharmaceuticals, radio frequency identification, glass strengthening technologies, and more. She is well versed in corporate actions including M&A, strategic messaging, and regulatory compliance.

Ms. Tomek began her investor relations and corporate communications career at RailAmerica, an acquirer and operator of short-line and regional railroads. She later went on to lead the investor relations department at Andrx Corporation, a manufacturer and distributor of generic and branded pharmaceuticals through the time of its acquisition by Watson Pharmaceuticals for $1.9 billion. She also established the IR department and participated in the initial public offering for VeriChip Corporation, a provider of RFID technologies for patient identification.  Ms. Tomek has also managed the IR function at a couple of OTC companies.

Ms. Tomek served as the two-term president and member of the South Florida chapter of the National Investor Relations Institute. She has also served as corporate secretary for the boards of directors of several public companies and in a director capacity. She earned her Bachelor of Science degree in News/Editorial from the School of Journalism and Mass Communication at the University of Colorado, Boulder.